Multiple recent articles and studies have highlighted that a large majority of hospitals are not taking part in CMS’ price transparency initiative. In fact, so few hospitals are following the price transparency requirements that CMS recently increased the penalty for non-compliance. Hospitals are not the only entity being pressured about price transparency. Pressure is also being put onto pharmaceutical companies, as high drug prices remain a high priority area for lawmakers. While hospitals are being scrutinized in the media, we will likely see more attention being placed on drug companies in the future. Read More >>>

Open document to read more; page 2.

View PDF